3/12
08:03 am
nerv
Minerva Neurosciences (NERV) had its "neutral" rating reaffirmed by HC Wainwright. They now have a $7.00 price target on the stock, up from $4.00.
Medium
Report
Minerva Neurosciences (NERV) had its "neutral" rating reaffirmed by HC Wainwright. They now have a $7.00 price target on the stock, up from $4.00.